Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.24 USD | +2.30% | +0.65% | +24.30% |
05-09 | ImmunityBio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-07 | ImmunityBio Shares Rise After Completion of Drug Substance Manufacturing for Cancer Treatment | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.30% | 4.32B | |
+18.77% | 125B | |
+14.05% | 108B | |
-7.16% | 23.64B | |
+2.07% | 22.39B | |
-10.79% | 17.78B | |
-41.74% | 16.43B | |
-13.47% | 16.34B | |
+2.23% | 13.56B | |
+27.13% | 11.59B |
- Stock Market
- Equities
- IBRX Stock
- News ImmunityBio, Inc.
- Transcript : NantKwest, Inc. Presents at 38th Annual J.P Morgan Healthcare Conference, Jan-14-2020 11